Author Archives: Bruno Quinney

Research in genetics laboratory
#Francis Crick Institute #Genetics #Neurodevelopmental disorders #University of Oxford

Research uncovers previously unknown recessive condition 

Researchers have discovered how genetic mutations can cause neuro-developmental disorders, including a previously unknown recessive condition.  Scientists at the University of Oxford and the Francis Crick Institute, in collaboration with international partners, have made advances in understanding how mutations in a single non-coding gene contribute to neurodevelopmental… Read More

#News

#Drug development #Personalised medicine #Regulatory

How is the regulatory landscape shaping drug development?

The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Robert Albarano and Kristina Capiak from Arthur D Little, who have experience maximising commercial success of drug discovery portfolios and securing FDA designations. Bruno speaks to Robert and Kristina about… Read More

#Featured Podcasts #Podcasts

Lilly Biotechnology Center
#AC Immune #Alzheimer's #Eli Lilly

AC Immune and Lilly reach agreement on drug collaboration 

Biopharmaceutical company AC Immune has reached an amended agreement with Eli Lilly for the development of an Alzheimer’s treatment.  The amendment to the 2018 license includes an agreement on the collaboration to research and develop Tau aggregation inhibitor small molecules for the potential treatment of Alzheimer’s disease (AD) and other neurodegenerative… Read More

#Business & Investment #News

#Alzheimer's #Clinical trial

Alzheon doses first patient with novel Alzheimer’s drug 

The first patient has been dosed in Alzheon’s Phase I trial of its Alzheimer’s drug.   The biopharmaceutical company dosed the patient in ALZ-507, a novel investigational oral drug candidate. The drug has been developed to target upstream amyloid aggregation and inhibit the formation of neurotoxic soluble amyloid… Read More

#News

Cancer research
#Cancer Grand Challenges #Cancer immunotherapy #CAR-T #Childhood cancer #Clinical trial

Trial to test CAR T-cell therapies as childhood cancer cures 

A first-of-its-kind trial has launched to explore whether personalised CAR T-cell immunotherapy could treat childhood cancers. The clinical trial, taking place in the UK and US, has enrolled a group of 60 children with cancer and offered them access to personalised investigational therapies. Researchers hope these investigational therapies… Read More

#Cancer Research #Editor's Choice #News

#AI / data analytics / healthtech / informatics #ALS #Alzheimer's #Axol Bioscience #Biologics #Centessa Pharmaceuticals #Corcept Therapeutics #Denali Therapeutics #Eli Lilly #FDA #Hunter Syndrome #LifeArc #Mergers and acquisitions #MND #Ovarian cancer #Stanford University

DDW Highlights: 7 April 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, there were crucial developments in neuroscience drug discovery. Elsewhere, a new treatment for… Read More

#Podcasts

Vaccine
#Breast cancer #Vaccines

Anixa and Cytovance partner to develop breast cancer vaccine 

Biotechnology company Anixa Biosciences has partnered with Cytovance Biologics to support the Phase II clinical trial of a breast cancer vaccine.  The vaccine, developed in collaboration with Cleveland Clinic, targets α-lactalbumin, a lactation-associated protein that is typically expressed only in breast tissue during lactation but which re-emerges in many forms of breast cancer.   By generating an immune response… Read More

#Business & Investment #News

#GPCRs #Nuclera

Nuclera launches GPCR-focused nanodisc panel 

Nuclera has announced the launched of a nanodisc panel focused on supporting G-Protein Coupled Receptors (GPCR) research and streamlining membrane protein production.  Building on the eProtein Discovery membrane protein workflow capabilities, the nanodisc panel allows membrane protein scientists focusing on GPCR research to identify optimal membrane environments and increase production of challenging therapeutic targets, GPCRs, producing active… Read More

#News

Colorectal cancer
#Clinical trial #Colorectal cancer #Prostate cancer

CuraCell doses first patient with TIL therapy 

Immunotherapy company CuraCell has dosed the first patients with its treatment for metastatic colorectal and metastatic prostate cancer.  CC-38 is novel autologous Tumour-Infiltrating Lymphocyte (TIL) therapy, currently being evaluated in Phase I/IIa trial. Up to 16 patients with Stage IV colorectal and prostate cancer will be enrolled in the trial, which will assess… Read More

#News

#Biotech #Broken String Biosciences

Broken String rebrands to support genome programmes 

Biotechnology company Broken String Biosciences has rebranded as the company repositions its strategic focus.  The company will now support early discovery programmes through to investigational new drug (IND)-enabling studies, moving away from its focus on being a specialist technology provider.  Broken String Biosciences, a company… Read More

#News

European Commission
#Clinical trial #European Commission #TK2d

EC grants marketing authorisation to rare disease drug 

The European Commission (EC) has granted marketing authorisation for Kygevvi (doxecitine and doxribtimine) for the treatment of thymidine kinase 2 deficiency (TK2d).  The approval, making Kygevvi the first and only treatment for TK2d, can now be used to treat paediatric and adult patients with the condition with an age of… Read More

#News #Regulatory

Child having ultrasound on knee
#Biopharma #City St George's #Osteoarthritis

City St George’s partners to develop new osteoarthritis drug 

City St George’s is partnering with drug development company Paradigm Biopharmaceuticals to test a drug that could become a new treatment option for osteoarthritis.  The UK-Australian partnership will investigate the effect of injectable pentosan polysulfate sodium (iPPS) – a drug currently being trialled for knee osteoarthritis by Paradigm Biopharmaceuticals… Read More

#News

#ALS #Axol Bioscience #LifeArc #MND

Global initiative to tackle gaps in ALS/MND drug discovery 

A global initiative has launched to close the gap in ALS/MND drug discovery.  The ALS Therapy Development Institute (ALS TDI), LifeArc, and Axol Bioscience announced the launch of ‘Patient induced pluripotent stem cell (iPSC)-based Research to Improve Sporadic ALS Modelling’ (PRISM ALS), a collaborative effort to expand access to high-quality, patient-derived stem… Read More

#News

Scientist in laboratory
#ABPI #Europe #Rare diseases #UK

UK must become leader in rare disease medicine, report says 

The UK should look to become a European leader in rare disease medicine, a new report says.  The report, ‘Investing in Rarity: The Economic and Personal Value of Improving Treatment for Rare Disease’, shows that if the UK became the best-performing European country on… Read More

#News

Neurons in a brain with Alzheimer's disease
#AI #Alzheimer's #Stanford University

AI-powered ‘co-scientist’ wins prestigious Alzheimer’s prize 

Developers of an AI-powered ‘co-scientist’ have been awarded the $1 million Alzheimer’s Insights AI Prize.  Mount Sinai scientists, led by Dr Kuan-lin Huang, won the prize for developing Biomni-AD, an advanced AI-powered ‘co-scientist’ designed to dramatically reduce the time required to generate scientific insights from complex biomedical data.  Biomni-AD… Read More

#News

Patient using a mammography machine
#Breast cancer #Tumour biology #University of California San Diego

Discovery sheds light on new way to treat breast cancer 

A new discovery into how breast cancer spreads could pave the way for a new treatment.  Researchers at the University of California San Diego found an inflammatory protein, TYK2, is involved in the process by which cells sense and respond to their physical environment, known as mechanotransduction.  … Read More

#Cancer Research #News